CanaQuest Medical Corp (CANQF)
0.1398
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
CanaQuest Medical 1 Year Total Returns (Daily): -30.10% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -30.10% |
May 02, 2024 | -22.28% |
May 01, 2024 | -22.22% |
April 30, 2024 | -17.60% |
April 29, 2024 | -17.66% |
April 26, 2024 | -17.66% |
April 25, 2024 | -15.21% |
April 24, 2024 | -17.65% |
April 23, 2024 | -17.65% |
April 22, 2024 | -11.82% |
April 19, 2024 | -11.82% |
April 18, 2024 | -16.72% |
April 17, 2024 | -0.17% |
April 16, 2024 | -0.17% |
April 15, 2024 | -30.06% |
April 12, 2024 | -30.06% |
April 11, 2024 | -18.89% |
April 10, 2024 | -18.89% |
April 09, 2024 | -66.39% |
April 08, 2024 | -18.94% |
April 05, 2024 | -18.94% |
April 04, 2024 | -14.06% |
April 03, 2024 | -14.06% |
April 02, 2024 | -44.44% |
April 01, 2024 | -44.44% |
Date | Value |
---|---|
March 28, 2024 | -44.44% |
March 27, 2024 | -44.44% |
March 26, 2024 | -44.44% |
March 25, 2024 | -44.50% |
March 22, 2024 | -44.50% |
March 21, 2024 | -44.50% |
March 20, 2024 | -44.50% |
March 19, 2024 | -44.44% |
March 18, 2024 | -44.44% |
March 15, 2024 | -44.44% |
March 14, 2024 | -41.11% |
March 13, 2024 | -11.78% |
March 12, 2024 | -16.78% |
March 11, 2024 | -16.78% |
March 08, 2024 | -11.72% |
March 07, 2024 | -11.72% |
March 06, 2024 | -11.72% |
March 05, 2024 | -11.72% |
March 04, 2024 | -24.15% |
March 01, 2024 | -11.72% |
February 29, 2024 | 5.83% |
February 28, 2024 | 5.83% |
February 27, 2024 | 5.77% |
February 26, 2024 | 5.77% |
February 23, 2024 | 5.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.34%
Minimum
Feb 23 2021
523.1%
Maximum
May 18 2020
30.56%
Average
-4.04%
Median
Jul 19 2022
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |